|1.||Verheyen, C C P M: 1 article (05/2008)|
|2.||Kuiper-Geertsma, D G: 1 article (05/2008)|
|3.||Rompen, J C: 1 article (05/2008)|
|4.||Sturkenboom, Miriam C J M: 1 article (03/2008)|
|5.||Laheij, Robert J F: 1 article (03/2008)|
|6.||Verheugt, Freek W A: 1 article (03/2008)|
|7.||Jansen, Jan B M J: 1 article (03/2008)|
|8.||van Oijen, Martijn G H: 1 article (03/2008)|
|9.||Dieleman, Jeanne P: 1 article (03/2008)|
|10.||Hulsebosch, Ronald: 1 article (01/2008)|
|1.||Migraine Disorders (Migraine)
11/01/1995 - "[Calcium carbasalate-metoclopramide combination versus dihydroergotamine in the treatment of migraine attacks]."
01/01/1999 - "Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks."
01/01/1999 - "This randomized, double-blind, double-dummy, multicenter, parallel-group study aimed at comparing the efficacy and safety of calcium carbasalate (equivalent to 900 mg aspirin) plus metoclopramide 10 mg (CM) with ergotamine tartrate 1 mg plus caffeine 100 mg (EC) administered in the treatment of 2 acute migraine attacks. "
|2.||Peptic Ulcer (Peptic Ulcers)
03/01/2008 - "The aim of the study was to investigate the incidence of peptic ulcers in a population-based cohort using bioequivalent low-dose acetylsalicylic acid (80 mg) or effervescent calcium carbasalate (100 mg). "
03/01/2008 - "The incidence rate of peptic ulcer disease is similar in patients using low-dose effervescent calcium carbasalate compared with regular low-dose acetylsalicylic acid. "
03/01/2008 - "The risk of peptic ulcers was not statistically significantly higher in patients using effervescent calcium carbasalate than in acetylsalicylic acid users (adjusted hazard ratio, 1.39; 95% confidence interval, 0.92-2.12). "
03/01/2008 - "The risk for developing a peptic ulcer during drug use was: 3.07 per 1000 person-years for acetylsalicylic acid and 4.31 for effervescent calcium carbasalate. "
03/01/2008 - "Incidence rates for documented peptic ulcer disease confirmed by endoscopy were calculated and time-dependent adjusted Cox regression analysis was used to compare the risk of peptic ulcers for patients using acetylsalicylic acid or effervescent calcium carbasalate. "
|1.||Aspirin (Acetylsalicylic Acid)
|3.||Ergotamine (Ergotamine Tartrate)
|4.||Caffeine (No Doz)